168 related articles for article (PubMed ID: 19394616)
1. Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.
Tselepis AD; Panagiotakos DB; Pitsavos C; Tellis CC; Chrysohoou C; Stefanadis C
Atherosclerosis; 2009 Sep; 206(1):303-8. PubMed ID: 19394616
[TBL] [Abstract][Full Text] [Related]
2. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
[TBL] [Abstract][Full Text] [Related]
3. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
[TBL] [Abstract][Full Text] [Related]
4. Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium.
Constantinides A; Kerstens MN; Dikkeschei BD; van Pelt LJ; Tellis CC; Tselepis AD; Dullaart RP
Eur J Clin Invest; 2012 Nov; 42(11):1235-43. PubMed ID: 22957745
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up.
Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD
J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
8. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
Onat A; Hergenç G; Can G; Uğur M; Nartop F
Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
[TBL] [Abstract][Full Text] [Related]
9. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.
Saougos VG; Tambaki AP; Kalogirou M; Kostapanos M; Gazi IF; Wolfert RL; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2236-43. PubMed ID: 17656665
[TBL] [Abstract][Full Text] [Related]
11. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
12. The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men.
Jang Y; Kim OY; Koh SJ; Chae JS; Ko YG; Kim JY; Cho H; Jeong TS; Lee WS; Ordovas JM; Lee JH
J Clin Endocrinol Metab; 2006 Sep; 91(9):3521-7. PubMed ID: 16787988
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation in lipoprotein-associated phospholipase A(2) (Lp-PLA(2)).
Kaminsky LA; Ozemek C
Clin Biochem; 2012 Jun; 45(9):700-2. PubMed ID: 22465237
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.
Persson M; Nilsson JA; Nelson JJ; Hedblad B; Berglund G
Atherosclerosis; 2007 Feb; 190(2):388-96. PubMed ID: 16530769
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
Chu AY; Guilianini F; Grallert H; Dupuis J; Ballantyne CM; Barratt BJ; Nyberg F; Chasman DI; Ridker PM
Circ Cardiovasc Genet; 2012 Dec; 5(6):676-85. PubMed ID: 23118302
[TBL] [Abstract][Full Text] [Related]
16. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
Noto H; Chitkara P; Raskin P
J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated phospholipase A2 mass is significantly reduced in dyslipidemic patients treated with lifestyle modification and combination lipid-modifying drug therapy.
Reddy KJ; Singh M; Batsell RR; Bangit JR; Miraskar RA; Zaheer MS
Prev Cardiol; 2010; 13(3):130-4. PubMed ID: 20626668
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M
Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
20. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
